Actively Recruiting

Phase 4
Age: 20Years +
All Genders
NCT05332444

Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection

Led by National Taiwan University Hospital · Updated on 2026-04-15

450

Participants Needed

1

Research Sites

242 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The prevalence of H. pylori antibiotic resistance has reached an alarming level worldwide. Antibiotic stewardship programs should be urgently developed and implemented. However, H. pylori antimicrobial susceptibility testing (AST) is rarely offered, making local resistance patterns not easily available. Guideline-recommended empiric therapies (GR-ET) may no longer reliably achieve high cure rate in the era of increasing antibiotic resistance. susceptibility-guided tailored therapy (SG-TT) may be a good choice to solve this problem. The aims of this study are: 1. to compare the efficacy of SG-TT with GR-ET as rescue regimens for H. pylori eradication; 2. to compare the patient adherence and adverse effects of these treatment regimens; 3. to investigate factors that may influence H. pylori eradication by these treatment regimens.

CONDITIONS

Official Title

Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection

Who Can Participate

Age: 20Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 20 years or older
  • Diagnosed with H. pylori-positive chronic gastritis with or without peptic ulcers (duodenal or gastric ulcers)
  • Have failed previous anti-H. pylori therapy and are seeking rescue treatment
Not Eligible

You will not qualify if you...

  • Pregnant or nursing women
  • Serious concomitant illnesses or any type of malignant tumor
  • History of hypersensitivity to the study drugs
  • Serious bleeding during the course of ulcers
  • Previous gastric surgery
  • Use of bismuth salts, proton pump inhibitors, or antibiotics within the past month

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

National Taiwan University Hospital

Taipei, Taiwan

Actively Recruiting

Loading map...

Research Team

J

Jyh-Chin Yang, M.D.Ph.D.

CONTACT

C

Chien-Chih Tung, M.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here